`ESTTA379700
`ESTTA Tracking number:
`11/22/2010
`
`Filing date:
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`91184464
`Plaintiff
`Medimmune, Inc.
`Defendant
`SYGNIS Pharma AG
`
`Proceeding.
`Applicant
`
`Other Party
`
`Motion for Suspension for Settlement With Consent
`
`The parties are actively engaged in negotiations for the settlement of this matter. Medimmune, Inc. requests
`that this proceeding be suspended for 90 days to allow the parties to continue their settlement efforts.
`
`CLOSED
`Time to Answer :
`CLOSED
`Deadline for Discovery Conference :
`CLOSED
`Discovery Opens :
`CLOSED
`Initial Disclosures Due :
`02/01/2011
`Expert Disclosure Due :
`03/03/2011
`Discovery Closes :
`04/17/2011
`Plaintiff's Pretrial Disclosures :
`06/01/2011
`Plaintiff's 30-day Trial Period Ends :
`06/16/2011
`Defendant's Pretrial Disclosures :
`07/31/2011
`Defendant's 30-day Trial Period Ends :
`08/15/2011
`Plaintiff's Rebuttal Disclosures :
`09/14/2011
`Plaintiff's 15-day Rebuttal Period Ends :
`Medimmune, Inc. has secured the express consent of all other parties to this proceeding for the suspension
`and resetting of dates requested herein.
`Medimmune, Inc. has provided an e-mail address herewith for itself and for the opposing party so that any
`order on this motion may be issued electronically by the Board.
`
`Certificate of Service
`
`The undersigned hereby certifies that a copy of this paper has been served upon all parties, at their address
`record by Facsimile or email (by agreement only) on this date.
`Respectfully submitted,
`/Constance Golden/
`Constance Golden
`cgolden@lawabel.com, Rdahl@lawabel.com
`efiling@kmob.com, mtimney@kmob.com
`11/22/2010